Mobile app version of munafa.us
Login or Join
 Learn then Earn
stockMarketNEWS

 story : AbbVie reports an increase in second-quarter revenue, led by sales of Humira #FinanceUSA #StockMarketNEWS Shares of AbbVie Inc. were down 1.3% in premarket trading on Friday though the company met

@stockMarketNEWS 19 Days ago

Posted in: #FinanceUSA #StockMarketNEWS

AbbVie reports an increase in second-quarter revenue, led by sales of Humira #FinanceUSA #StockMarketNEWS
Shares of AbbVie Inc. were down 1.3% in premarket trading on Friday though the company met earnings and revenue expectations for the second quarter of the year. AbbVie had earnings of 4 million, or 51 cents per share, in the second quarter of this year, compared with 6 million, or 42 cents per share, in the same quarter a year ago. Adjusted earnings per share were .37, against a FactSet consensus of .32. The company reported that revenue increased to .58 billion in the second quarter of 2022, compared with .96 billion in the same three months of last year. The FactSet consensus was .6 billion. AbbVie's rheumatoid arthritis drug remains its top-selling therapy; the treatment generated .3 billion in revenue for the quarter, up from .1 billion in the same quarter a year ago. Botox Cosmetic sales jumped to .3 billion in the quarter, up from 4 million in the same quarter a year ago. The company reaffirmed its guidance for 2022. AbbVie's stock is up 10.6% this year, while the broader S&P 500 has declined 14.5%.


Munafa USA Munafa India Munafa NSE


Report

Login to follow story

More posts by @stockMarketNEWS

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

Daily analysis, news, Munafa stocks list in email:

Back to top | Use Dark Theme